The Interleukin-6 (IL-6) Inhibitors Market is experiencing sustained growth as targeted therapies continue to transform the treatment of chronic inflammatory and autoimmune disorders. Interleukin-6 (IL-6) is a key cytokine involved in immune regulation and inflammatory signaling, making it an important therapeutic target for several immune-mediated diseases. According to Polaris Market...